Question 1

What is the Partnership for Safe Medicines?

Accepted Answer

The Partnership for Safe Medicines (PSM) is an organization that works to protect the safety of drugs and medicines. They are experts on medicine safety issues and often provide insight and perspective to journalists.

Question 2

What are some of the challenges with drug counterfeiting?

Accepted Answer

The PSM warns about the dangers of widespread counterfeiting of transformative drugs like Ozempic and Mounjaro, which has led to a boom in compounding and counterfeit production. They emphasize the importance of understanding the risks associated with counterfeit medicines.

Question 3

Is it safe or cost-effective to import medicines from other countries?

Accepted Answer

The PSM advises that importing medicines from Canada or other countries is not safe or effective. They argue that relying on foreign drug supplies can pose significant risks to patients.

Question 4

What is the impact of the counterfeit pill crisis?

Accepted Answer

The counterfeit pill crisis is now a decade old, and the PSM warns that the fake pill trade is not going away. They emphasize the need for continued awareness and action to address this ongoing threat to public health.

Question 5

How do prescription drug affordability boards (PDABs) impact medicine access?

Accepted Answer

The PSM notes that while PDABs are intended to control medicine costs, some of their strategies may have unintended consequences. The organization provides updates on PDAB activity and their potential impact on patients and the healthcare system.

Partnership for Safe Medicines

Company Overview

Company Name

Address

Website

Phone

About Partnership for Safe Medicines

Frequently Asked Questions about Partnership for Safe Medicines

What is the Partnership for Safe Medicines?

What are some of the challenges with drug counterfeiting?

Is it safe or cost-effective to import medicines from other countries?

What is the impact of the counterfeit pill crisis?

How do prescription drug affordability boards (PDABs) impact medicine access?

Social Profiles

Key Decision Makers